Life Science & BioTech in Angel Investment
As a part of the Atlanta Technology Angels’ investor education program, we are pleased to invite you to a program on investing in Life Science & BioTech. The session will be held from 5:30 to 7:30 pm on Tuesday, March 18, in the Georgian Club in the Cobb Galleria. As usual, we will start with cocktails and hors d’oeuvres.
Life Science & BioTech companies face different challenges than traditional technology startups. Intellectual property, government regulations, Medicare reimbursement, longer development periods, and higher capital requirements are factors that influence these companies and investors alike. While we know how to assess a technology company’s market opportunity, business model, financing strategy, competitive analysis and legal situation, how does that translate into an assessment for Life Science & BioTech companies? To educate us in this area, the March program will be devoted to a discussion of the Life Science & Biotech side of angel investing.
To help us, we will have two expert speakers leading the discussion:
*** Rachael Hagan, Coulter Program Director at The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, will speak about the factors and challenges faced by Life Science & BioTech startup companies.
**** Tom Callaway, Venture Partner at HealthQuest Capital, will speak about venture capital investment in Life Science & Biotech and the investment focus that HealthQuest Capital uses to analyze and fund the growth of companies.
Attendance is free to ATA members and sponsors, $25 for members of MIT Enterprise Forum of Atlanta, and $35 for guests.
For registration, please CLICK HERE
If you have any questions, please contact email@example.com.
Michael Horten - Education Chair